Terms: = Liver cancer AND NT5C2, ENSG00000076685, 22978, P49902, PNT5, NT5B, GMP, cN-II
53 results:
1. Simultaneous Activation of Immunogenic Cell Death and cGAS-STING Pathway by liver- and Mitochondria-Targeted Gold(I) Complexes for Chemoimmunotherapy of Hepatocellular Carcinoma.
Li F; Wen Z; Wu C; Yang Z; Wang Z; Diao W; Chen D; Xu Z; Lu Y; Liu W
J Med Chem; 2024 Feb; 67(3):1982-2003. PubMed ID: 38261008
[TBL] [Abstract] [Full Text] [Related]
2. High-Load Gemcitabine Inorganic-Organic Hybrid Nanoparticles as an Image-Guided Tumor-Selective Drug-Delivery System to Treat Pancreatic cancer.
Ischyropoulou M; Sabljo K; Schneider L; Niemeyer CM; Napp J; Feldmann C; Alves F
Adv Mater; 2023 Nov; 35(46):e2305151. PubMed ID: 37587542
[TBL] [Abstract] [Full Text] [Related]
3. HBV confers innate immune evasion through triggering HAT1/acetylation of H4K5/H4K12/miR-181a-5p or KPNA2/cGAS-STING/IFN-I signaling.
Zhao L; Yuan H; Wang Y; Geng Y; Yun H; Zheng W; Yuan Y; Lv P; Hou C; Zhang H; Sun J; Sun L; Suo Y; Wang S; Zhang N; Lu W; Yang G; Zhang X
J Med Virol; 2023 Jul; 95(7):e28966. PubMed ID: 37466313
[TBL] [Abstract] [Full Text] [Related]
4. Automated Synthesis and Preclinical Evaluation of Optimized Integrin α6-Targeted Positron Emission Tomography Imaging of Pancreatic cancer.
Chen L; Fu H; He H; Lou K; Li Q; Ye J; Feng G; Yu C
Mol Pharm; 2023 Aug; 20(8):4277-4284. PubMed ID: 37463487
[TBL] [Abstract] [Full Text] [Related]
5. Live Mycobacterium paragordonae induces heterologous immunity of natural killer cells by eliciting type I interferons from dendritic cells via STING-dependent sensing of cyclic-di-gmp.
Lee MH; Kim BR; Seo H; Oh J; Kim HL; Kim BJ
Microbes Infect; 2023; 25(7):105144. PubMed ID: 37120009
[TBL] [Abstract] [Full Text] [Related]
6. Pattern recognition receptors in the development of nonalcoholic fatty liver disease and progression to hepatocellular carcinoma: An emerging therapeutic strategy.
Huang C; Zhou Y; Cheng J; Guo X; Shou D; Quan Y; Chen H; Chen H; Zhou Y
Front Endocrinol (Lausanne); 2023; 14():1145392. PubMed ID: 37020586
[TBL] [Abstract] [Full Text] [Related]
7. Manufacturing and validation of Good Manufacturing Practice-compliant regulatory dendritic cells for infusion into organ transplant recipients.
Zahorchak AF; DeRiggi ML; Muzzio JL; Sutherland V; Humar A; Lakkis FG; Hsu YS; Thomson AW
Cytotherapy; 2023 Apr; 25(4):432-441. PubMed ID: 36639251
[TBL] [Abstract] [Full Text] [Related]
8. Hyperbaric oxygen facilitates teniposide-induced cGAS-STING activation to enhance the antitumor efficacy of PD-1 antibody in HCC.
Li K; Gong Y; Qiu D; Tang H; Zhang J; Yuan Z; Huang Y; Qin Y; Ye L; Yang Y
J Immunother Cancer; 2022 Aug; 10(8):. PubMed ID: 36002188
[TBL] [Abstract] [Full Text] [Related]
9. Targeting of GSDMD sensitizes HCC to anti-PD-1 by activating cGAS pathway and downregulating PD-L1 expression.
Lv T; Xiong X; Yan W; Liu M; Xu H; He Q
J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35688553
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic Perspectives of STING and PD-L1 Expression and Correlation with the Prognosis of Epstein-Barr Virus-Associated Gastric cancers.
Sun Q; Fu Y; Chen X; Li L; Wu H; Liu Y; Xu H; Zhou G; Fan X; Xia H
Gut Liver; 2022 Nov; 16(6):875-891. PubMed ID: 35611665
[TBL] [Abstract] [Full Text] [Related]
11. Blocking CD47 promotes antitumour immunity through CD103
Wang S; Wu Q; Chen T; Su R; Pan C; Qian J; Huang H; Yin S; Xie H; Zhou L; Zheng S
J Hepatol; 2022 Aug; 77(2):467-478. PubMed ID: 35367532
[TBL] [Abstract] [Full Text] [Related]
12. Preclinical evaluation of [
Estrada S; Elgland M; Selvaraju RK; Mani K; Tegler G; Wanhainen A; Wågsäter D; Bergström M; Jimenez-Royo P; Jahan M; Nordeman P; Antoni G
Nucl Med Biol; 2022; 106-107():62-71. PubMed ID: 35066391
[TBL] [Abstract] [Full Text] [Related]
13. Engineering pH-Sensitive Stable Nanovesicles for Delivery of MicroRNA Therapeutics.
Boloix A; Feiner-Gracia N; Köber M; Repetto J; Pascarella R; Soriano A; Masanas M; Segovia N; Vargas-Nadal G; Merlo-Mas J; Danino D; Abutbul-Ionita I; Foradada L; Roma J; Córdoba A; Sala S; de Toledo JS; Gallego S; Veciana J; Albertazzi L; Segura MF; Ventosa N
Small; 2022 Jan; 18(3):e2101959. PubMed ID: 34786859
[TBL] [Abstract] [Full Text] [Related]
14. Compound Kushen Injection intervenes metabolic reprogramming and epithelial-mesenchymal transition of HCC via regulating β-catenin/c-Myc signaling.
Wang KX; Du GH; Qin XM; Gao L
Phytomedicine; 2021 Dec; 93():153781. PubMed ID: 34649212
[TBL] [Abstract] [Full Text] [Related]
15. Hypoxia-induced RNASEH2A limits activation of cGAS-STING signaling in HCC and predicts poor prognosis.
Zhao F; Liu A; Gong X; Chen H; Wei J; Chen B; Chen S; Yang R; Fan Y; Mao R
Tumori; 2022 Feb; 108(1):63-76. PubMed ID: 34165025
[TBL] [Abstract] [Full Text] [Related]
16. The cGAS-STING Pathway: Novel Perspectives in liver Diseases.
Xu D; Tian Y; Xia Q; Ke B
Front Immunol; 2021; 12():682736. PubMed ID: 33995425
[TBL] [Abstract] [Full Text] [Related]
17. Natural Killer Cells and Regulatory T Cells Cross Talk in Hepatocellular Carcinoma: Exploring Therapeutic Options for the Next Decade.
Bozward AG; Warricker F; Oo YH; Khakoo SI
Front Immunol; 2021; 12():643310. PubMed ID: 33995362
[TBL] [Abstract] [Full Text] [Related]
18. Identification of prognostic biomarkers and correlations with immune infiltrates among cGAS-STING in hepatocellular carcinoma.
Qi Z; Yan F; Chen D; Xing W; Li Q; Zeng W; Bi B; Xie J
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33006365
[TBL] [Abstract] [Full Text] [Related]
19. ATR inhibitor AZD6738 enhances the antitumor activity of radiotherapy and immune checkpoint inhibitors by potentiating the tumor immune microenvironment in hepatocellular carcinoma.
Sheng H; Huang Y; Xiao Y; Zhu Z; Shen M; Zhou P; Guo Z; Wang J; Wang H; Dai W; Zhang W; Sun J; Cao C
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461345
[TBL] [Abstract] [Full Text] [Related]
20.
Vallejo-Armenta P; Santos-Cuevas C; Soto-Andonaegui J; Villanueva-Pérez RM; González-Díaz JI; García-Pérez FO; Arrellano-Zarate A; Luna-Gutiérrez M; Azorín-Vega E; Ocampo-García B; Ferro-Flores G
Contrast Media Mol Imaging; 2020; 2020():2525037. PubMed ID: 32410920
[TBL] [Abstract] [Full Text] [Related]
[Next]
